Arlington Capital Management, Inc. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 393 filers reported holding VANECK VECTORS ETF TR in Q1 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Arlington Capital Management, Inc. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2018$10,503,000
-49.7%
477,866
-46.8%
10.94%
-29.6%
Q4 2017$20,869,000
-1.5%
897,990
-2.7%
15.55%
+41.1%
Q3 2017$21,184,000
+79.3%
922,641
+72.4%
11.02%
+127.8%
Q2 2017$11,817,000
-3.5%
535,191
-0.3%
4.84%
+6.9%
Q1 2017$12,249,000
+14.6%
537,009
+5.1%
4.53%
+15.8%
Q4 2016$10,693,000
-19.3%
511,103
+2.0%
3.91%
-29.5%
Q3 2016$13,249,000501,2575.55%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2018
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders